2018
DOI: 10.1016/j.ygyno.2018.04.143
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of MYB is associated with growth and malignant behavior of ovarian cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Previously,MYB is one of the proto-oncogenes, it has become a consensus that there is a relationship between MYB overexpression and poor prognosis of OC. Using the correlation between MYB and OC to evaluate the prognosis and explore potential therapeutic targets has attracted much attention [ 33 35 ]. But, the study found that MYB-77867-ES for OC prognosis is favorable AS event.…”
Section: Discussionmentioning
confidence: 99%
“…Previously,MYB is one of the proto-oncogenes, it has become a consensus that there is a relationship between MYB overexpression and poor prognosis of OC. Using the correlation between MYB and OC to evaluate the prognosis and explore potential therapeutic targets has attracted much attention [ 33 35 ]. But, the study found that MYB-77867-ES for OC prognosis is favorable AS event.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, we used data from TCGA database, combined with high-throughput sequencing technology and bioinformatics to analyze the relationship between AS, SF and the prognosis of OC.In addition, independent prognostic factors of OC, GO, KEGG analysis of pathways for prognostic related SFs were also explored.Consistent with other studies, our study shows that AS events and SFs play a role in OC, and many splicing events are associated with OC.With the increase of the sample size in this study, the number of AS events in OC was also 48049, with the highest number of ES type [15].After further treatment, the AS events of TSEN54, MYB, SERF1B, ZNF630 and AGO2 were most closely associated with the prognosis of OC, and they were all good prognostic factors.tRNA splicing endonuclease(TSEN) catalyz tRNA intron removal in eukaryotes,and TSEN54 is a TSEN is one of the core subunits.The gene mutation of TSEN54 mostly leads to nervous system lesions, most studied cause of pontocerebellar hypoplasia.There has been a lack of research on the relationship between OC [30][31][32].Previously,MYB is one of the proto-oncogenes, it has become a consensus that there is a relationship between MYB overexpression and poor prognosis of OC. Using the correlation between MYB and OC to evaluate the prognosis and explore potential therapeutic targets has attracted much attention [33][34][35].But,the study found that MYB-77867-ES for OC prognosis is favorable AS event. The results suggest that splicing may change the role of genes.AGO2 is a Protein Coding gene, which have effect on cervical cancer, breast cancer and other tumors [36][37][38].AGO2 fail in our study it happened happened AGO2-85285-ES is bene cial to the prognosis of OC, but in other studies, AGO2 can have opposite effects on the prognosis of OC through different pathways [39][40][41].Few studies have been done on SERF1B and ZNF630,we get SERF1B-72406-RI ZNF630-88949-AP close contact with OC, they may be effective prognostic biomarkers and therapeutic targets.Among the remaining results, there are many previous studies on CD44 gene.As a non-kinase transmembrane receptor,CD44 can be used as an effective biomarker to predict the prognosis of OC and negatively affect the outcome of OC [42].CD44 plays a multi-functional role, such as related to cancer stem cells and tumor-associated macrophages, leading to drug resistance of recurrent chemotherapy drugs in OC.…”
Section: Discussionmentioning
confidence: 99%